Tartrate-resistant acid phosphatase 5b (TRAP 5b) as a marker of osteoclast activity in the early phase after cementless total hip replacement

Acta Orthopaedica

Volumn 78, Issue 2, 2007, Pages 221-225

  Habermann, Bjoern ^a   Eberhardt, Christian ^a   Feld, Matthias ^a   Zichner, Ludwig ^a   Kurth, Andreas A ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE BONE ISOENZYME; BIOLOGICAL MARKER; OSTEOCALCIN;

ADULT; AGED; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; BONE METABOLISM; BONE REMODELING; CELL ACTIVITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME ANALYSIS; FEMALE; HUMAN; MALE; OSTEOBLAST; OSTEOCLAST; OSTEOPENIA; PREDICTION; PROSPECTIVE STUDY; TOTAL HIP PROSTHESIS;

ACID PHOSPHATASE; ADULT; AGED; ALKALINE PHOSPHATASE; ARTHROPLASTY, REPLACEMENT, HIP; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; BONE RESORPTION; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOCALCIN; OSTEOCLASTS; PROSPECTIVE STUDIES; PROSTHESIS FAILURE; TARTRATES;

EID: 34247618717     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.1080/17453670710013717     Document Type: Article

References (16)

1. Aldinger P R, Sabo D, Pritsch M, Thomasen M, Mau H, Ewerbeck V, Breusch S J. Pattern of periprosthetic bone remodelling around stable uncemented tapered hip stems: a prospective 84-month follow up study and a median 156-month cross-sectional study with DXA. Calcif Tissue Int 2003; 73: 115-21.
2. Brodner W, Bitzan P, Lomoschitz F, Krepler P, Jankovsky R, Lehr S, Kainberger F, Gottsauner. Changes in bone mineral density in the proximal femur after cementless total hip arthroplasty. A five-year longitudinal study. J Bone Joint Surg (Br) 2004; 86: 20
3. Brown A, Papp J, Reiter A. The periprosthetic bone remodelling process - signs of vital bone reaction. Int Orthop 2004; 27: S7-10
4. Halleen J, Hentunen T A, Hellmann J, Väänänen H K. Tartrate-resistant acid phosphatase from human bone: purification and development of an immunoassay. J Bone Min Res 1996; 11: 1444-52.
5. Halleen J, Räisänen S, Salo J J, Hentunen T A, Reddy S V, Roodman D G, Lehenkari P P, Kaija H, Vihko P, Väänänen HK. Intracelluar fragmentation of bone resorption products by reactive oxygene species generated by osteoclastic tartrate-resistant acid phosphatase. J Biol Chem 1999; 274: 22907-10.
6. Halleen J M, Alatalo S L, Suominen H, Cheng S, Janckila A J, Väänänen H K. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. J Bone Miner Res 2000; 15: 1337-445.
7. Halleen J M, Alatalo S L, Janckila A J, Woitge H W, Sebel M J, Väänänen H K. Tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption. Clin Chem 2001; 47: 597-600.
8. Nishii T, Sugano N, Masuhara K, Shibuya T, Ochi T, Tamura S. Longitudinal evaluation of time ralated bone remodelling after cementless total hip arthroplasty. Clin Orthop 1997; (339): 121-31.
9. Pagani F, Francucci C M, Moro L. Markers of bone turnover: biochemical and clinicla perspectives. J Endorcinol Invest 2005; 28 (10S): 8-13.
10. Pellengahr C, Mayer W, Durr H R, Maier M, Muller P, Veihelmann A, Zysk S, Jansson V, Refior H J. The value of desoxypyridinoline in the diagnostic of loosened arthroplasty. Arch Orthop Trauma Surg 2001; 121 (4): 205-6.
11. Rahmy A I, Gonsens T, Blake G M, Tonino A, Fogelman I. Periprosthetic bone remodelling of two types of uncemented femoral implant with proximal hydroxyapatite coating: a 3-year follow-up study addressing the influence of prosthesis design and preoperative bone density on periprosthtic bone loss. Osteoporos Int 2003; 6: Epub.
12. Venesmaa P K, Kroger H P, Miettinen H J, Jurvelin J S, , Suomalainen O T, Alhava E M. Bone loss around failed femoral implant measured by dual-energy-x-ray absorptiometry. J Orthop Sci 2000; 5: 380-4.
13. Venesmaa P K, Kroger H P, Jurvelin J S, Miettinen H J, Suomalainen O T, Alhava E M. Periprosthetic bone loss after cemented total hip arthroplasty; a prospective 5-year dual energy radiographic absorptiometry study of 15 patients. Acta Orthop Scand 2003; 74 (1): 31-6.
14. Wilkinson J M, Peel N F A, Elson R A, Stockley I, Eastell R. Measuring bone mineral density of the pelvis and proximal femur after total hip arthroplasty. J Bone Joint Surg (Br) 2001; 83: 283-8.
15. Wilkinson J M, Hamer A J, Rogers A, Stockley I, Eastell R. Bone mineral density and biochemical markers of bone turnover in aseptic loosening after total hip arthroplasty. J Orthop Res 2003; 21: 691-6.
16. Witzleb W C, Menschikowski M. Urinary concentration of collagen metabolits in endoprosthesis loosening. Z Orthop Grenzgeb 2001; 139 (3): 240-4.